Tokyo, Japan

Norihito Murayama



 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Osaka, JP (2006)
  • Tokyo, JP (2013 - 2015)
  • Minato-ku, JP (2014 - 2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Norihito Murayama: Innovator in Pharmaceutical Chemistry

Introduction

Norihito Murayama is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of nitrogen-containing six-membered aromatic ring derivatives. With a total of 5 patents, his work has the potential to impact various medical conditions.

Latest Patents

Murayama's latest patents focus on compounds that promote axonal outgrowth and angiogenesis. These compounds can be utilized to reduce central nerve injuries, including head injuries, spinal cord injuries, cerebral infarction, ischemic heart diseases, and peripheral arterial occlusive diseases. The innovative compounds are characterized by a formula that includes a nitrogen-containing six-membered aromatic ring, which is crucial for their therapeutic effects.

Career Highlights

Throughout his career, Norihito Murayama has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Daiichi Sankyo Company, Limited and Daiichi Asubio Pharma Co., Ltd. His expertise in pharmaceutical development has been instrumental in advancing medical research and treatment options.

Collaborations

Murayama has collaborated with notable colleagues, including Naohiro Takemoto and Kenji Murata. These partnerships have fostered innovation and contributed to the success of various projects in the pharmaceutical sector.

Conclusion

Norihito Murayama's contributions to pharmaceutical chemistry exemplify the impact of innovative research on medical advancements. His work continues to pave the way for new treatments that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…